
Dr. Solon Gonçalves Souza Menezes
Professor of Surgery — FAMED UFU · Board certification in Digestive System Surgery (CBCD/AMB) · Robotic Surgery certification (Intuitive / Albert Einstein Hospital) · Practices at UMC and Mater Dei Santa Genoveva Hospitals, Uberlândia-MG · (34) 99341-0915
Appendix cancer, also called vermiform appendix tumor or appendiceal neoplasm, is a rare condition, identified in fewer than 1% of surgical specimens removed by appendectomy. It comprises different histological types, including neuroendocrine tumors (the most frequent), mucinous adenocarcinoma, and non-mucinous adenocarcinoma, each with distinct biological behavior and prognosis. In most cases, the diagnosis is incidental: the patient undergoes surgery for suspected acute appendicitis — pain in the right lower quadrant of the abdomen, nausea, low-grade fever, and tenderness on palpation — and the tumor is discovered only on histopathological analysis of the removed appendix. Less commonly, the condition presents with progressive abdominal distension, a palpable mass, or symptoms related to mucinous spread within the peritoneal cavity, known as pseudomyxoma peritonei, which requires specialized investigation and management.
Definitive diagnosis of appendix cancer almost always depends on histopathological examination of the surgical specimen, since imaging studies — computed tomography of the abdomen and pelvis, magnetic resonance imaging, and, when indicated, colonoscopy — have a limited role in the preoperative detection of these tumors, and are more useful for staging and for evaluating possible peritoneal spread. Tumor markers such as CEA, CA 19-9, and CA 125 can assist in monitoring mucinous cases. For this reason, surgery plays a central role in treatment: it confirms the actual extent of the disease, removes the tumor, and guides the need for complementary therapies. Surgical planning for these cases is conducted by Dr. Solon Gonçalves, a surgeon certified in Digestive System Surgical Oncology by the Brazilian College of Digestive Surgery (Colégio Brasileiro de Cirurgia Digestiva, CBCD), a society affiliated with the Brazilian Medical Association (Associação Médica Brasileira, AMB), practicing in Uberlândia-MG.
The choice of surgical technique depends on the histological type, tumor size, invasion of the appendiceal base, and lymph node involvement identified in the surgical specimen or on staging exams. Small neuroendocrine tumors (generally smaller than 1 to 2 cm), localized and without mesoappendiceal invasion, can be treated with simple appendectomy alone. Larger tumors, adenocarcinomas, intermediate- or high-risk neuroendocrine tumors, or those with a compromised margin, indicate oncologic right colectomy with regional lymphadenectomy, performed via open, laparoscopic, or robotic approach, depending on the characteristics of the case. In cases of peritoneal mucinous spread, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) may be discussed at specialized centers. Adjuvant systemic chemotherapy is considered in selected cases of adenocarcinoma with risk factors, always decided jointly with clinical oncology.
What to expect before and after surgery.
Preoperative preparation
Preoperative preparation for surgical treatment of appendix cancer generally involves additional imaging exams, laboratory evaluation, and pre-anesthesia assessment, the details of which tend to vary according to the patient's clinical status and the extent of the planned procedure (oncologic appendectomy, right colectomy, or more extensive surgery). In some cases, bowel preparation and adjustment of ongoing medications may be requested, always according to individualized guidance from the care team. Fasting and suspension of certain medications in the days before surgery are generally indicated, but the exact timeframes vary from patient to patient. These recommendations are general and should always be confirmed and adjusted case by case by the responsible surgeon.
Recovery and postoperative care
Recovery after surgical treatment of appendix cancer typically involves pain control, a gradual return to diet, and early mobilization, with length of hospital stay and return to regular activities varying according to the technique used (open, laparoscopic, or robotic) and each patient's progress. Follow-up exams and, when indicated, additional treatment are generally defined together with the oncology team after review of the pathology report. Signs such as fever, severe pain, or discharge from the incision should generally be reported promptly to the medical team. These timeframes and guidelines are general in nature and may be adjusted individually during postoperative follow-up.
Common questions about this procedure.
What are the symptoms of appendix cancer?+
In most cases, appendix cancer causes no specific symptoms and is discovered incidentally during an appendectomy performed for suspected acute appendicitis — pain in the right lower quadrant of the abdomen, nausea, and low-grade fever. In larger tumors or with peritoneal spread, progressive abdominal distension, a sensation of fullness, a palpable mass, or changes in bowel habits may occur. In the presence of persistent abdominal pain, the patient should seek medical evaluation for proper investigation.
How is appendix cancer diagnosed?+
Diagnosis is often established only after histopathological examination of the appendix removed during an appendectomy. When there is prior suspicion, computed tomography of the abdomen and pelvis and magnetic resonance imaging help assess tumor extent and peritoneal spread, while colonoscopy may be indicated to rule out associated lesions in the colon. Tumor markers such as CEA, CA 19-9, and CA 125 assist in monitoring mucinous cases but do not replace histological confirmation.
How long does oncologic appendectomy or right colectomy surgery take?+
Duration varies according to the technique indicated. An oncologic appendectomy usually takes between 40 and 90 minutes, while a right colectomy with lymphadenectomy, performed via open, laparoscopic, or robotic approach, generally lasts between 2 and 4 hours. Cases with peritoneal spread that require cytoreductive surgery combined with HIPEC can extend for several hours. The exact duration depends on intraoperative findings and should be discussed individually before the procedure.
What type of anesthesia is used for this surgery?+
These procedures are performed under general anesthesia, with a prior pre-anesthetic evaluation to check the patient's clinical condition. In some protocols, complementary analgesia, such as abdominal wall blocks, is added to reduce the need for opioids after surgery. The final choice of anesthetic technique is made by the anesthesiology team, together with the surgeon, considering the extent of the surgery and the patient's health history.
How long is the hospital stay?+
After an isolated oncologic appendectomy, discharge usually occurs within 1 to 2 days. Right colectomy generally requires 3 to 5 days of hospitalization, which may vary according to the patient's progress, the surgical approach used, and the presence of comorbidities. More extensive surgeries, such as cytoreductive procedures with HIPEC, require a longer hospital stay. These timeframes are estimates and may change according to individual recovery.
Is pain after surgery severe?+
Discomfort is expected, especially in the first 48 to 72 hours, and is usually controlled with scheduled analgesia, combining anti-inflammatory drugs, common analgesics, and, when necessary, opioids at adjusted doses. Laparoscopic or robotic procedures tend to involve less incisional pain than the open approach. The intensity and duration of pain vary according to the extent of the surgery and each patient's individual sensitivity.
Is a drain or catheter necessary after surgery?+
In simple appendectomies, a drain is generally not necessary. In right colectomies or more extensive surgeries, the surgeon may opt for the temporary use of an abdominal drain and a urinary catheter, removed within the first postoperative days according to clinical progress. A nasogastric tube is used only in specific situations. The need for these devices is assessed on a case-by-case basis, during surgery and postoperative follow-up.
What do the surgical scars look like?+
With the laparoscopic or robotic approach, the scars are small incisions, generally between 0.5 and 1.2 cm, distributed across the abdomen. With the open approach, when indicated, the incision is usually larger, in the right lower quadrant or midline region, depending on the extent of the resection. The final appearance of the scar varies according to each patient's individual healing pattern and postoperative care, and should be discussed with the surgeon beforehand.
How long is the patient away from work?+
For light activities, return to work after oncologic appendectomy usually occurs between 1 and 2 weeks. After right colectomy, time away generally ranges from 3 to 4 weeks, and may be longer for jobs requiring physical effort. These timeframes are approximate: they depend on the surgical approach, the occurrence of complications, and individual recovery, and should be confirmed by the responsible surgeon during follow-up.
What are the risks, complications, and contraindications of this surgery?+
As with any abdominal surgery, there are risks of bleeding, surgical site infection, fistula or anastomotic dehiscence in colectomy, injury to adjacent structures, and thromboembolic events. Cases with extensive peritoneal spread may be contraindicated for cytoreductive surgery, depending on the peritoneal carcinomatosis index. Severe comorbidities and unstable clinical conditions may require prior optimization. Each case is evaluated individually with regard to risks and benefits.
Is chemotherapy always necessary? Who else is involved in treatment besides the surgeon?+
Not every case requires additional treatment: small, localized neuroendocrine tumors treated with appendectomy usually do not require chemotherapy. Adenocarcinomas with risk factors or peritoneal spread, however, may require systemic or intraperitoneal chemotherapy, determined jointly with clinical oncology. Follow-up usually involves a surgical oncologist, a clinical oncologist, a pathologist, and, when necessary, a clinical nutritionist, always individualized according to staging.
Hospital facilities in Uberlândia, Brazil.
Hospital Mater Dei Santa Genoveva
Av. Vasconcelos Costa, 967 — Martins, Uberlândia-MG
Open in Google Maps →Content reviewed by Dr. Solon Gonçalves Souza Menezes — CRM-MG 79366, RQE 60355 (GI Surgery), RQE 44656 (General Surgery). Professor of Surgery at FAMED-UFU and Supervisor of the General Surgery Medical Residency Program at HC-UFU. ORCID. Last reviewed: September/2026.
- Nash GM, Smith JD, Tang L, et al. Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers. Ann Surg Oncol. 2015;22(11):3613-3617. doi:10.1245/s10434-015-4415-5
- Pawa N, Clift AK, Osmani H, et al. Surgical Management of Patients with Neuroendocrine Neoplasms of the Appendix: Appendectomy or More. Neuroendocrinology. 2018;106(3):242-251. doi:10.1159/000478742
- Govaerts K, Lurvink RJ, De Hingh IHJT, et al. Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines. Eur J Surg Oncol. 2021;47(1):11-35. doi:10.1016/j.ejso.2020.02.012
- Kusamura S, Delhorme JB, Taibi A, et al. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Pseudomyxoma Peritonei. Ann Surg Oncol. 2024;31(9):6262-6273. doi:10.1245/s10434-024-15646-6
